by admin | Mar 28, 2025 | press-releases
Home PRESS RELEASE CG Oncology Reports 2024 Year End Financial Results and Provides Business Updates π» DESKTOP AUDIO PLAYER =============================== --> Listen to this article now 0:00 π± MOBILE AUDIO PLAYER =============================== --> Listen to this...
by admin | Mar 24, 2025 | press-releases
Home PRESS RELEASE Cretostimogene Grenadenorepvec Data Continues to Demonstrate Best-in-Class Durability of Response as well as Consistent and Compelling Safety and Efficacy π» DESKTOP AUDIO PLAYER =============================== --> Listen to this article now 0:00 π±...
by admin | Mar 12, 2025 | press-releases
Home PRESS RELEASE CG Oncology to Participate in the 40th Annual European Association of Urology Congress with a Series of Key Presentations and Updates Listen to this article now β Late-breaking clinical and first translational data from BOND-003 Cohort C will be...
by admin | Feb 26, 2025 | press-releases
Home PRESS RELEASE CG Oncology to Present at the TD Cowen 45th Annual Health Care Conference Listen to this article now IRVINE, Calif., Feb. 26, 2025 (GLOBE NEWSWIRE) — CG Oncology, Inc. (NASDAQ: CGON), a late-stage clinical biopharmaceutical company focused on...
by admin | Dec 16, 2024 | press-releases
Home PRESS RELEASE CG Oncology Completes Public Offering & Share Purchase π» DESKTOP AUDIO PLAYER =============================== --> Listen to this article now 0:00 π± MOBILE AUDIO PLAYER =============================== --> Listen to this article now 0:00 0.5x...
by admin | Dec 12, 2024 | press-releases
Home PRESS RELEASE CG Oncology Announces Pricing of Public Offering π» DESKTOP AUDIO PLAYER =============================== --> Listen to this article now 0:00 π± MOBILE AUDIO PLAYER =============================== --> Listen to this article now 0:00 0.5x 0.75x Normal...